Probing the limits of Q-tag bioconjugation of antibodies
Site-selective labelling of antibodies (Abs) can circumvent problems from heterogeneity of conventional conjugation. Here, we evaluate the industrially-applied chemoenzymatic ‘Q-tag’ strategy based on transglutaminase-mediated (TGase) amide-bond formation in the generation of 89Zr-radiolabelled anti...
Main Authors: | Marculescu, C, Lakshminarayanan, A, Gault, J, Knight, JC, Folkes, LK, Spink, T, Robinson, CV, Vallis, K, Davis, BG, Cornelissen, B |
---|---|
Format: | Journal article |
Published: |
Royal Society of Chemistry
2019
|
Similar Items
-
Scaling-down antibody radiolabeling reactions with zirconium-89
by: Knight, JC, et al.
Published: (2016) -
An efficient system for bioconjugation based on a widely applicable engineered O-glycosylation tag <subtitle>Short title: Controlled bioconjugation via O-glycan engineering</subtitle>
by: Thomas V. Murray, et al.
Published: (2021-01-01) -
Liquid phase separation techniques for the characterization of monoclonal antibodies and bioconjugates
by: Ettore Gilardoni, et al.
Published: (2022-11-01) -
Bioconjugation of a PNA Probe to Zinc Oxide Nanowires for Label-Free Sensing
by: Teresa Crisci, et al.
Published: (2021-02-01) -
Engineering a Novel Modular Adenoviral mRNA Delivery Platform Based on Tag/Catcher Bioconjugation
by: Kexin Geng, et al.
Published: (2023-11-01)